The true toxicity of Veklury © (remdesivir)

Did the Gilead company hide the true toxicity of Veklury © (remdesivir) ?

Concerns about the approval and widespread use of Veklury © (remdesivir) for treating COVID-19, questioning its efficacy, toxicity, and potential hidden side effects.

The analysis criticizes the lack of clear data on the drug's safety profile, highlighting the absence of information on adverse events and drug interactions.

We the peoples suggests that the pharmaceutical company, Gilead, may be downplaying the toxicity of Remdesivir and calls for a thorough investigation into its potential harm.

The article also questions the timing of Veklury's © introduction into the market, emphasizing the need for transparency and comprehensive safety assessments before endorsing its widespread use.